Arca
Skip to content
Tools
Tools

Charlotte ACC25 Surface Electrode Array and 1 more

Electrode, Cutaneous. 510(k) K261442, from Cadwell Industries, Inc. (Kennewick, WA). Product code GXY, class 2.

As of Nov 18, 2026, K261442 is an FDA 510(k) held by Cadwell Industries, Inc., substantially equivalent on Jun 26, 2026 after 57 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 26, 2026
  • Review time: 57 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Charlotte Surface Electrode Arrays are indicated for non -invasive use with recording and monitoring equipment to acquire physiological electrical signals from Electromyography (EMG), Electroencephalograph (EEG) and Evoked Potentials (EP). Summary of

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other GXY Clearances

The newest 510(k)s for the same product code; their median review was 144 days; see every GXY device

Record

Type
Abbreviated
Received
Apr 30, 2026
Review panel
Neurology
Regulation
21 CFR 882.1320

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.